Artivion Stock Performance
| AORT Stock | USD 30.72 0.13 0.42% |
On a scale of 0 to 100, Artivion holds a performance score of 14. The firm shows a Beta (market volatility) of 0.67, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Artivion's returns are expected to increase less than the market. However, during the bear market, the loss of holding Artivion is expected to be smaller as well. Please check Artivion's potential upside, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether Artivion's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Artivion are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Artivion unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 3:2 | Ex Dividend Date 2015-12-09 | Last Split Date 2000-12-28 |
1 | Disposition of 5000 shares by Matthew Getz of Artivion at 19.94 subject to Rule 16b-3 | 04/10/2025 |
2 | Artivion in Royce Small-Cap Opportunity Fund Q3 2024 | 04/14/2025 |
3 | Artivion Reports First Quarter 2025 Financial Results | 05/05/2025 |
4 | Disposition of 19092 shares by Jean Holloway of Artivion at 21.55 subject to Rule 16b-3 | 05/09/2025 |
5 | Artivion Announces Agreements to Exchange 95 Million in Principal Amount of its 4. ... | 05/14/2025 |
6 | Disposition of 9926 shares by Jean Holloway of Artivion at 29.0 subject to Rule 16b-3 | 05/21/2025 |
7 | Disposition of 2600 shares by Anthony Semedo of Artivion at 28.472 subject to Rule 16b-3 | 05/23/2025 |
8 | Director Anthony Semedo Sells 2,600 Shares of Artivion Inc | 05/27/2025 |
9 | Artivion Announces Closing of Transactions to Exchange 99.5 Million in Principal Amount of its 4.250 percent Convertible Notes Due 2025 for Common Stock | 05/28/2025 |
10 | Q1 Earnings Highs And Lows Artivion Vs The Rest Of The Medical Devices Supplies - Cardiology, Neurology, Vascular Stocks | 05/29/2025 |
11 | Artivion Inc Announces Participation in Upcoming Investor Conferences AORT stock news | 06/03/2025 |
12 | Disposition of 1826 shares by Marshall Stanton of Artivion at 28.4277 subject to Rule 16b-3 | 06/13/2025 |
13 | Artivion Inc Shares Up 3.78 percent on Jun 17 | 06/17/2025 |
14 | Artivion SVP Stanton sells 442k in company stock - Investing.com | 06/18/2025 |
15 | Legacy Advisors LLC Makes New 28,000 Investment in Artivion, Inc. | 06/26/2025 |
16 | Artivion, Inc. Given Consensus Recommendation of Buy by Analysts | 07/01/2025 |
| Begin Period Cash Flow | 58.9 M |
Artivion Relative Risk vs. Return Landscape
If you would invest 2,309 in Artivion on April 7, 2025 and sell it today you would earn a total of 763.00 from holding Artivion or generate 33.04% return on investment over 90 days. Artivion is currently generating 0.4933% in daily expected returns and assumes 2.6141% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Artivion, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Artivion Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Artivion's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Artivion, and traders can use it to determine the average amount a Artivion's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1887
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AORT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.61 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.49 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Artivion is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Artivion by adding it to a well-diversified portfolio.
Artivion Fundamentals Growth
Artivion Stock prices reflect investors' perceptions of the future prospects and financial health of Artivion, and Artivion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Artivion Stock performance.
| Return On Equity | -0.0726 | ||||
| Return On Asset | 0.0154 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 1.77 B | ||||
| Shares Outstanding | 47.04 M | ||||
| Price To Book | 4.91 X | ||||
| Price To Sales | 3.70 X | ||||
| Revenue | 388.54 M | ||||
| Gross Profit | 249.41 M | ||||
| EBITDA | 38.87 M | ||||
| Net Income | (13.36 M) | ||||
| Cash And Equivalents | 40.38 M | ||||
| Cash Per Share | 1.00 X | ||||
| Total Debt | 362.26 M | ||||
| Debt To Equity | 1.27 % | ||||
| Book Value Per Share | 6.89 X | ||||
| Cash Flow From Operations | 22.24 M | ||||
| Earnings Per Share | (0.51) X | ||||
| Total Asset | 789.1 M | ||||
| Retained Earnings | (61.27 M) | ||||
About Artivion Performance
Assessing Artivion's fundamental ratios provides investors with valuable insights into Artivion's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Artivion is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company was founded in 1984 and is headquartered in Kennesaw, Georgia. Artivion operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 1300 people.Things to note about Artivion performance evaluation
Checking the ongoing alerts about Artivion for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Artivion help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 388.54 M. Net Loss for the year was (13.36 M) with profit before overhead, payroll, taxes, and interest of 249.41 M. | |
| Artivion has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Artivion, Inc. Given Consensus Recommendation of Buy by Analysts |
- Analyzing Artivion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Artivion's stock is overvalued or undervalued compared to its peers.
- Examining Artivion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Artivion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Artivion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Artivion's stock. These opinions can provide insight into Artivion's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Artivion Stock Analysis
When running Artivion's price analysis, check to measure Artivion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artivion is operating at the current time. Most of Artivion's value examination focuses on studying past and present price action to predict the probability of Artivion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artivion's price. Additionally, you may evaluate how the addition of Artivion to your portfolios can decrease your overall portfolio volatility.